Background and purpose -The Synovasure lateral fl ow test was developed as a rapid test for the detection or exclusion of periprosthetic joint infection (PJI). 3 studies have reported promising results on its diagnostic value in total joint revision surgery. We aimed to assess the sensitivity and specifi city of the Synovasure test to exclude infection in patients undergoing revision surgery for suspected early aseptic loosening of a total hip or knee arthroplasty.
Background and purpose -The Synovasure lateral fl ow test was developed as a rapid test for the detection or exclusion of periprosthetic joint infection (PJI). 3 studies have reported promising
results on its diagnostic value in total joint revision surgery. We aimed to assess the sensitivity and specifi city of the Synovasure test to exclude infection in patients undergoing revision surgery for suspected early aseptic loosening of a total hip or knee arthroplasty.
Patients and methods -In a prospective study design, 37 patients who underwent revision surgery for suspected early aseptic loosening (< 3 years after primary arthroplasty) were included. The Synovasure test was used intraoperatively to confi rm the aseptic nature of the loosening and 6 tissue cultures were obtained in all cases. Exclusion criteria were patients with a preoperatively confi rmed PJI, acute revisions (< 90 days after primary arthroplasty) and cases with malpositioning, wear, or instability of the prosthesis.
Results -5 of the 37 patients were diagnosed with a PJI based on the intraoperative tissue cultures. In only 1 out of these 5 cases this was confi rmed by the intraoperative Synovasure test. No tests were falsely positive.
Interpretation -In this case series the Synovasure lateral fl ow test had a low sensitivity to exclude PJI in patients with suspected aseptic loosening. The role of the Synovasure lateral fl ow test in the intraoperative exclusion of PJI during revision surgery for suspected early aseptic loosening appears to be more limited than previously indicated.
■
Periprosthetic joint infection (PJI) accounts for up to 25% of failed total knee arthroplasties (TKA) and up to 15% of failed total hip arthroplasties (THA) (Bozic et al. 2009 (Bozic et al. , 2010 .
Distinguishing the septic from the aseptic failures in total joint arthroplasty (TJA) is critical in the successful treatment of painful prosthetic joints, as they require different surgical strategies. To this end, the Musculoskeletal Infection Society has formulated criteria for decision-making in the work-up of suspected of PJI (Parvizi et al. 2011) . However, this work-up remains far from straightforward, mainly since there is no uniform test for diagnosing PJI (Parvizi et al. 2011) . Therefore, a simple diagnostic tool for PJI would be important.
Recently, the presence of the α-defensin biomarker in synovial fl uid was suggested as a possible marker of periprosthetic joint infection, since it is naturally released by neutrophils in the presence of synovial fl uid pathogens (Ganz et al. 1985 , Deirmengian et al. 2015b . 3 studies using quantitative measurements of α-defensin have reported a sensitivity and specifi city above 96% for PJI (Deirmengian et al. 2014a (Deirmengian et al. , 2014b (Deirmengian et al. , 2015a .
From these reported high sensitivity and specifi city of α-defensin levels in detecting PJI, the Synovasure test (Zimmer Inc., Warsaw, IN, USA), a lateral fl ow test for the detection of α-defensin levels, has been made commercially available. The Synovasure lateral fl ow test is a rapid measure of the α-defensin levels in synovial fl uid, and provides dichotomic results after 10 minutes. 2 studies reported a sensitivity (67-69%) and specifi city (93-94%) lower than in the previously mentioned quantitative measurements (Kasparek et al. 2016 , Sigmund et al. 2017 ). However, a recent study by Berger et al. (2017) reported higher sensitivity (97%) and specifi city (97%).
The previously mentioned studies were performed in nonspecifi c patient populations containing varying indications for revision surgery ranging from evident acute PJI to reimplantation in 2-stage PJI revisions. However, the true clinical value of this promising test may lie in its ability to intraoperatively distinguish the early (< 3 years following implantation) aseptic failure, where a 1-stage revision is indicated, from the early septic failure with less virulent micro-organisms where a staged revision would be more appropriate.
In this study we evaluated the additional value of the intraoperative Synovasure lateral fl ow test in confi rming the absence of PJI in a group of patients undergoing prosthetic joint revision surgery for suspected early aseptic loosening. The results of the Synovasure test were compared with intraoperative tissue cultures. Furthermore, we assessed the possible correlation of false-negative test results with the presence of metallosis, since previous studies have suggested that metallosis may predispose to false-positive results (Bonanzinga et al. 2017 ).
Patients and methods
Since August 2015, the Synovasure test has been used in our clinic as an adjunct tool to exclude PJI intraoperatively in revision patients with suspected early aseptic loosening of an implanted THA or TKA. Cases were prospectively included in the presence of a chronically painful (> 90 days) prosthetic joint in those who underwent revision surgery due to suspected early aseptic loosening (< 3 years after primary arthroplasty) of the implant after TKA or THA between August 2015 and October 2017. During revision surgery on these patients in this period, the Synovasure test was used to aid in the exclusion of PJI. Excluded from this study were patients already diagnosed with PJI according to the MSIS criteria, acute revisions (< 90 days), revisions due to dislocations, revisions due to malpositioning, or cases where an insuffi cient amount of synovial fl uid could be aspirated to perform the Synovasure lateral fl ow test.
In all cases, synovial fl uid was aspirated under aseptic conditions (after surgical dissection up to the joint capsule) from the affected joint whilst avoiding any contamination with blood. The Synovasure test was carried out according to the manufacturer's instructions. In the case of a positive Synovasure test, we considered the joint to be infected and proceeded with the removal of the prosthesis and implantation of a spacer containing antibiotics. If the test was negative, we proceeded with a one-stage revision of the affected joint. In all cases, a total of 6 microbiologic cultures of synovial tissue and the interface membrane were collected. The tissue samples were cultured for 14 days in the microbiology laboratory. Tissue cultures were considered positive for PJI when at least 2 out of 6 cultures grew identical pathogens. During surgery, the presence of metallosis or macroscopic signs of infection (presence of pus) were noted.
Ethics, funding, and potential confl icts of interest
The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2000. This research received no specifi c grant from any funding agency in the public, commercial, or not-for-profi t sectors. No competing interests were declared.
Results
37 patients (22 men), mean age 66 (51-81) years, planned for revision surgery met the inclusion criteria. Revision surgery was performed on 8 hips and 29 knees. 5 patients were diagnosed with PJI due to positive tissue cultures. Of these, 1 patient had a positive Synovasure test and 4 patients tested negative. Thus, there were 1 true-positive Synovasure test, and 4 false-negative Synovasure tests (Table) . No false-positive Synovasure tests were observed, even in the presence of metallosis.
4 false-negative cases were observed; all these patients were treated as 1-stage revisions for PJI with adequate antibiotics over the course of 12 weeks.
The only true positive test occurred in a patient with intraoperative macroscopic signs of infection due to the presence of pus. In this patient, previous tests did not indicate PJI according to the MSIS criteria; however, 6 intraoperative tissue cultures grew Staphylococcus epidermidis. 29 true negative tests were observed; in 1 of these cases metallosis was present during surgery.
Discussion
The identifi ed sensitivity (1/5) is clearly lower than reported in previous studies (Kasparek et al. 2016 , Berger et al. 2017 , Sigmund et al. 2017 . These 3 earlier studies reported a sensitivity of 67-97% and specifi city of 93-96% of the Synovasure test for the diagnosis of PJI In contrast to our study these studies included various kinds of procedures, namely: patients fulfi lling the MSIS criteria for PJI preoperatively, 1-stage revisions, reimplantations at second-stage revision, explantations and spacer implantations, spacer exchanges, debridements with exchange of mobile parts and retention of the prosthesis and excision of a hip prosthesis (Sigmund et al. 2017) . Kasparek et al. (2016) also included cases with varying indications: aseptic loosening, polyethylene wear with osteolysis, suspected chronic PJI, patients fulfi lling the MSIS criteria for PJI preoperatively, instability and stiffness. Berger et al. (2017) included patients fulfi lling a modifi ed version of the MSIS criteria for PJI preoperatively. This modifi cation, and the non-specifi c patient populations including varying indications for revision surgery, makes the reported values diffi cult to interpret and compare. Even more so in establishing the tests' ability to distinguish early aseptic failure from septic failure in unclear cases that are not evidently infected (not fulfi lling the modifi ed MSIS criteria for PJI). In contrast to these earlier studies our study focused on the ability of the Synovasure test to exclude PJI in a uniform subgroup of patients undergoing revision surgery for suspected early aseptic loosening. To our knowledge, this is the fi rst study to assess the Synovasure lateral fl ow test in this specifi c homogeneous subgroup of patients. From clinical practice this is an important strength of our study and as such is the fi nding of a rather low sensitivity in this particular subgroup. This strength has to be balanced against the limitation of a rather small number of patients included, which warrants caution in drawing fi rm conclusions. Another strength of our study, and that of Sigmund et al. (2017) , is that there is no confl ict of interest in relation to the manufacturer of the Synovasure test.
Previous studies have suggested that the presence of metallosis may predispose to false-positive results of the Synovasure test. In our study, there was 1 case of metallosis, which yielded a negative Synovasure test.
Our fi ndings indicate that the Synovasure lateral fl ow test has limited additional value for the intraoperative exclusion of PJI from low virulent micro-organisms (i.e. Staphylococcus epidermidis and Proprionibacterium acnes) in a homogeneous subgroup of patients with suspected early aseptic failures of THA and TKA. This is an important limitation in the clinical use of the test, which initially promised to be ideal in simply confi rming or excluding any PJI intraoperatively. The sensitivity may be improved by aiming future research at fi ne-tuning the thresholds of α-defensin in the presence of low-virulent micro-organisms. This may, however, be diffi cult to achieve since recent reviews failed to establish a more accurate cut-off value. The latter was due to the usage of different techniques among laboratories and a shortage of well-designed studies (Li et al. 2017 , Yuan et al. 2017 .
It should also be noted that the dichotomic nature of the Synovasure lateral fl ow test, where the presence or absence of a PJI is claimed, is another limitation. Irrespective of the fact that a solution may be found to decrease the relatively high chance of a false-negative test outcome in case of low-virulent agents, the microbial agents and their resistance patterns would still have to be obtained from prolonged tissue cultures.
For that reason future research should also continue to focus on advances in molecular microbiology and techniques for detecting microbial infections (e.g., susceptibility testing, DNA amplifi cation assays) (Maurer et al. 2017) . These techniques may offer increased diagnostic resolution and are not dichotomic by also providing information on the causative pathogen's identity and resistance pattern. Further improvement on these earlier mentioned microbial detection techniques may eventually bypass the dependency on tissue cultures for adequate antibiotic treatment.
